Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention

Published:2006-10 Issue:8 Volume:48 Page:1560-1566
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Patti Giuseppe,Chello Massimo,Pasceri Vincenzo,Colonna Diego,Nusca Annunziata,Miglionico Marco,D’Ambrosio Andrea,Covino Elvio,Di Sciascio Germano

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study;Pasceri;Circulation,2004

2. A randomized trial of high loading dose of clopidogrel for reduction of peri-procedural myocardial infarction in patients undergoing coronary intervention;Patti;Circulation,2005

3. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC;Morikawa;J Atheroscler Thromb,2002

4. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage;Paajarvi;FASEB J,2005

5. Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin;Nawawi;Atherosclerosis,2003

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of preprocedural statin loading on clinical outcomes in patients undergoing elective percutaneous coronary intervention;Frontiers in Cardiovascular Medicine;2024-08-20

2. Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection;Redox Biology;2023-11

3. Association between NLRP3 inflammasome and periprocedural myocardial injury following elective PCI;Heliyon;2023-08

4. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning;Pharmacological Reviews;2022-12-08

5. An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect;Neuro-Oncology Advances;2022-01-01